Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cholangiocarcinoma Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT03117855
What this trial is testing

Capecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That Cannot Be Removed by Surgery

Who this might be right for
Bile Duct AdenocarcinomaStage III Intrahepatic CholangiocarcinomaStage IVA Intrahepatic Cholangiocarcinoma+1 more
City of Hope Medical Center
Not applicableUnknownNCT06763250
What this trial is testing

In This Study, a Retrospective Analysis Was Conducted to Explore the Risk Factors for Patients Undergoing Pancreaticoduodenal Surgery (PD) to Achieve TO, and a Nomogram Prediction Model Was Further Established to Promote the Standardization and Standardization of PD Surgical Quality Evaluation.

Who this might be right for
Pancreatic CarcinomaCholangiocarcinomaPancreaticoduodenectomy
luokai zhang 280
Large-scale testing (Phase 3)Study completedNCT02853474
What this trial is testing

Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy

Who this might be right for
Gastric CancerPancreas CancerBile Duct Cancer+2 more
Centre Oscar Lambret 480
Testing effectiveness (Phase 2)Looking for participantsNCT06313203
What this trial is testing

HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)

Who this might be right for
Intrahepatic CholangiocarcinomaChemotherapy Effect
Oslo University Hospital 39
Testing effectiveness (Phase 2)Study completedNCT00003923
What this trial is testing

Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer+1 more
Memorial Sloan Kettering Cancer Center 4
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Not applicableUnknownNCT06048289
What this trial is testing

Prospective Observational Study to Predict the Response of Biliary Tract Tumors to Immunotherapy

Who this might be right for
Biliary Tract TumorCholangiocarcinoma
Zhejiang Cancer Hospital 150
Large-scale testing (Phase 3)Ended earlyNCT04093362
What this trial is testing

Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

Who this might be right for
Advanced CholangiocarcinomaFGFR2 Gene Rearrangements
Taiho Oncology, Inc. 10
Testing effectiveness (Phase 2)UnknownNCT00356161
What this trial is testing

HAI Via Interventionally Implanted Port Catheter Systems

Who this might be right for
Colorectal CancerLiver NeoplasmsHepatocellular Carcinoma+2 more
Charite University, Berlin, Germany 100
Early research (Phase 1)Looking for participantsNCT06840886
What this trial is testing

PHST001 in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsOvarian CancerEndometrial Cancer+2 more
Pheast Therapeutics 272
Testing effectiveness (Phase 2)UnknownNCT00553683
What this trial is testing

Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Rutgers, The State University of New Jersey 50
Testing effectiveness (Phase 2)Ended earlyNCT04727541
What this trial is testing

Neoadjuvant Bintrafusp Alfa in Patients With Resectable Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerCholangiocarcinoma
AIO-Studien-gGmbH 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07623642
What this trial is testing

A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.

Who this might be right for
Uterine Cervical NeoplasmsTriple Negative Breast NeoplasmsProstatic Neoplasms+8 more
GV20 Therapeutics 227
Early research (Phase 1)Study completedNCT04164069
What this trial is testing

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+13 more
Anne Noonan 9
Testing effectiveness (Phase 2)Looking for participantsNCT05532059
What this trial is testing

Lenvatinib, Tislelizumab Plus Gemcitabine and Cisplatin (GPLET) in Patients with Advanced Cholangiocarcinoma

Who this might be right for
Advanced Cholangiocarcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 100
Early research (Phase 1)Study completedNCT04672434
What this trial is testing

Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 48
Testing effectiveness (Phase 2)Study completedNCT02232633
What this trial is testing

BBI503 in Adult Patients With Advanced Hepatobiliary Cancer

Who this might be right for
Hepatocellular CarcinomaCholangiocarcinoma
Sumitomo Pharma America, Inc. 45
Testing effectiveness (Phase 2)Ended earlyNCT00975039
What this trial is testing

Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Steba Biotech S.A. 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT06777316
What this trial is testing

An FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)CholangiocarcinomaOther Solid Tumors, Adult+9 more
Cogent Biosciences, Inc. 110
Large-scale testing (Phase 3)UnknownNCT03086993
What this trial is testing

Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma

Who this might be right for
Bile Duct CancerIntrahepatic Cholangiocarcinoma
Delcath Systems Inc. 295
Next Page